Home » Topics » Regulatory » Patents

Patents
RSS

Shionogi discloses ACC2 inhibitors

Oct. 20, 2016

Merck & Co. patents TrK-A inhibitors

Oct. 20, 2016

Arisan Therapeutics presents RNA polymerase inhibitors

Oct. 19, 2016

Celon Pharma develops PI3Kdelta inhibitors

Oct. 19, 2016

Enanta Pharmaceuticals describes FXR agonists

Oct. 19, 2016

Shenyang Sunshine Pharmaceutical discloses EGLN1 inhibitors

Oct. 19, 2016

Takeda Pharmaceutical patents enteropeptidase inhibitors

Oct. 19, 2016

Toray Industries presents kappa-opioid agonists

Oct. 18, 2016

Jubilant Biosys develops HUNK1 inhibitors

Oct. 18, 2016

Takeda Pharmaceutical describes MGL inhibitors

Oct. 18, 2016

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...